Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation

Liver Transplantation

Volumn 12, Issue 5, 2006, Pages 754-761

  Machicao, Victor I ^a   Srinivas, Titte R ^a   Hemming, Alan W ^a   Soldevila Pico, Consuelo ^a   Firpi, Roberto J ^a   Reed, Alan I ^a   Morelli, Giuseppi J ^a   Nelson, David R ^a   Abdelmalek, Manal F ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DOSE CALCULATION; DRUG BLOOD LEVEL; FEMALE; HEMODIALYSIS; HEPATITIS C; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY TRANSPLANTATION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOGENESIS; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; COHORT STUDIES; CREATININE; FEMALE; HUMANS; INCIDENCE; KIDNEY; KIDNEY DISEASES; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PREVALENCE; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 33646443963     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20686     Document Type: Article

References (32)

1. Annual Report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network. Transplant Data 1990-1999. UNOS, Richmond, VA, and the Division of Transplantation, Bureau of Health Resources and Services Administration, US Department of Health and Human Services, Rockville, MD, 2000.
2. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33: 464-470.
3. Brown RS Jr, Kumar KS, Russo MW, Kinkhabwala M, Rudow DL, Harren P, et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pre-transplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002;8: 278-284.
4. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91-96.
5. Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003;9:117-123.
6. Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, et al. MELD score predicts 1-year patient survival post orthotopic liver transplantation. Liver Transpl 2003;9:473-476.
7. Jacob AM, Copley LP, Lewsey JD, Gimson A, Toogood GJ, Rela M, Van der Meulen JHP. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl 2004;10:903-907.
8. Nair S. Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002;35:1179-1185.
9. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM. Levy MF, Klintmalm GB. End-stage renal disease (ESRD) following orthotopic liver transplantation (OLTX) utilizing calcineurin based immunothcohortpy: risk of development and treatment. Transplantation 2001;72:1934-1939.
10. Cohen AJ, Stegall MD, Rosen CB, Wiesner RH, Leung N, Kremers KW, Zein NN. Chronic renal dysfunction late after liver transplantation. Liver Transpl 2002;8:916-921.
11. Pawarode A. Fine DM, Thuluvath PJ. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 2003;9:741-747.
12. United Network for Organ Sharing. Available at http://www.unos.org. Accessed July 2005.
13. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2001;24:S5-S20.
14. Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/ International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-1992.
15. Kalayoglu M, Sollinger HW, Stratta RJ, D'Alessandro AM, Hoffmann RM, Pirsch JD, Belzer FO. Extended preservation of the liver for clinical transplantation. Lancet 1988; 1:617-619.
16. Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg 1989;210:649-652.
17. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
18. Harnois DM, Steers J, Andrews JC, Rubin JC, Pitot HC, Burgart LC, et al. Preopcohorttive hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 1999;5: 192-199.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Diet and Renal Disease Study Group. Ann Inter Med 1999;130:461-470.
20. Levey AS, Coresh J, Balk E. Kausz AT, Levin A. Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;129:137-147.
21. Demetris AJ, Batts KP, Dhillon AP, Ferrell L, Fung J, Geller SA, et al. Banff Schema for Grading Liver Allograft Rejection: An International Consensus Document. Hepatology 1997;25:658-663.
22. Cox DR. Regression models and life tables. JR Stat Soc 1972 34:187-220.
23. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871.
24. Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Narayanan Menon KV et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005;41:353-358.
25. Farnsworth N, Fagan S, Berger D, Awad S. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg 2004;188:580-583.
26. Paramesh AS, Roayaie S, Doan Y, Schwartz ME, Emre S, Fishbein T, et al. Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease. Clin Transpl 2004;18:94-99.
27. Platz KP; Mueller AR; Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P. Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506 treated patients. Transpl Int 1994;7:S52-S57
28. Lucey MR., Abdelmalek MF, Gagliardi R, Granger D, Holt C, Kam I, et al. A Comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. Am J Transpl 2005;5:1111-1119.
29. McClellan WM. Epidemiology and risk factors for chronic kidney disease. Med Clin North Am 2005;89:419-445.
30. Jager KJ, van Dijk PC, Dekker FW, Stengel B, Simpson K, Briggs JD; ERA-EDTA Registry Committee. The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomes. Clin Nephrol 2003;60: 352-360.
31. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349:931-940.
32. Trail KC, Stratta RJ, Larsen JL, Ruby EI, Patil KD, Langnas AN, et al. Results of liver transplantation in diabetic recipients. Surgery 1993;114:650-658.